Long-term Outcome of Intravitreal Aflibercept Treatment for Neovascular Age-Related Macular Degeneration Using a "Treat-and-Extend" Regimen. [electronic resource]
Producer: 20200110Description: 393-399 p. digitalISSN:- 2468-6530
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- administration & dosage
- Drug Administration Schedule
- Female
- Humans
- Intravitreal Injections
- Macular Degeneration -- drug therapy
- Male
- Middle Aged
- Receptors, Vascular Endothelial Growth Factor -- administration & dosage
- Recombinant Fusion Proteins -- administration & dosage
- Retrospective Studies
- Visual Acuity
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.